1. Home
  2. OFAL vs IMRN Comparison

OFAL vs IMRN Comparison

Compare OFAL & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OFAL

OFA Group Ordinary Shares

HOLD

Current Price

$0.66

Market Cap

7.7M

ML Signal

HOLD

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$0.82

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OFAL
IMRN
Founded
2013
1994
Country
United States
Australia
Employees
10
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.2M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
OFAL
IMRN
Price
$0.66
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
93.6K
19.6K
Earning Date
07-31-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$0.68
52 Week High
$7.39
$2.38

Technical Indicators

Market Signals
Indicator
OFAL
IMRN
Relative Strength Index (RSI) 73.15 55.69
Support Level $0.60 $0.69
Resistance Level $0.73 $0.89
Average True Range (ATR) 0.06 0.06
MACD 0.03 0.01
Stochastic Oscillator 86.31 67.52

Price Performance

Historical Comparison
OFAL
IMRN

About OFAL OFA Group Ordinary Shares

OFA Group, through its subsidiary, provides architectural services, including design and fit-out services for commercial and residential buildings in Hong Kong. The design service includes both the consultation with staff and the actual design work and the company provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, among other things, budgetary consideration, optimal use of space, the materials, fittings, furniture, appliances and other items to be used to produce a preliminary design plan and quotation. Its works include installing protective materials to cover floors or walls, installing or constructing partition walls, windows, window frames, and decorative fittings, furniture or fixtures, installing plumbing systems, etc.

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Share on Social Networks: